| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |